Federal contract award
75F40120C00198
PMQWP#243 - EFFECT OF REPEAT UNIT ORDERING ON THE PROPERTIES OF MELT-EXTRUDED, POLY(LACTIDE-COGLYCOLIDE)- BASED, LONG-ACTING,IMPLANTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AZ11 — OTHER RESEARCH AND DEVELOPMENT - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.1M |
| Current contract value | $1.1M |
| Potential contract value / ceiling | $1.1M |
| Start date | Sep 29, 2020 |
| Current end date | Sep 30, 2024 |
| Potential end date | Sep 30, 2024 |
| Latest award activity | Jul 22, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 22, 2025 | P00004 | $-4.4K | EFFECT OF REPEAT UNIT ORDERING ON THE PROPERTIES OF MELT-EXTRUDED, POLY(LACTIDE-COGLYCOLIDE)- BASED, LONG-ACTING,IMPLANTS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.